DNA damage repair (DDR) gene mutations (mut) are predictors of response to platinum-based chemotherapy in advanced pancreatic cancer (PC) patients (pts)

被引：0

作者：

Verdaguer, H. ^{[1
]}

Guardiola, M. ^{[2
]}

Mancuso, F. M. ^{[3
]}

Acosta Eyzaguirre, D. A. ^{[4
]}

Buxo, E. ^{[1
]}

Hernando, J. ^{[5
]}

Diez Garcia, M. ^{[4
]}

Laquente, B. ^{[6
]}

Baraibar Argota, I. ^{[7
]}

Ros Montana, F. J. ^{[8
]}

Garcia-Alvarez, A. ^{[4
]}

Matito, J. ^{[3
]}

Martin, A. ^{[3
]}

Sierra, A. ^{[9
]}

Villacampa Javierre, G. ^{[10
]}

Molero, C. ^{[11
]}

Miquel, J. M. ^{[11
]}

Vivancos, A. ^{[12
]}

Dienstmann, R. ^{[13
]}

Macarulla Mercade, T. ^{[14
]}

机构：

[1] Vall dHebron Univ Hosp, Inst Oncol, Med Onol, Barcelona, Spain

[2] Vall dHebron Univ Hosp, Inst Oncol, Oncol Data Sci, Barcelona, Spain

[3] Vall dHebron Inst Oncol VHIO, Canc Genom, Barcelona, Spain

[4] Vall dHebron Univ Hosp, Med Oncol Dept, Barcelona, Spain

[5] Vall Hebron Univ Hosp, Vall Hebron Inst Oncol VHIO, Med Oncol Dept, Barcelona, Spain

[6] Hosp Duran & Reynals, ICO Inst Catala Oncol, Med Oncol Dept, Lhospitalet De Llobregat, Spain

[7] Vall dHebron Univ Hosp, Med Oncol, Barcelona, Spain

[8] Vall dHebron Univ Hosp, Oncol, Barcelona, Spain

[9] VHIO, Prescreening Program, Barcelona, Spain

[10] Vall dHebron Inst Oncol VHIO, Stat Dept, Barcelona, Spain

[11] Vall dHebron Inst Oncol VHIO, Project Managment, Barcelona, Spain

[12] Vall dHebron Univ Hosp, Genom, Barcelona, Spain

[13] Vall dHebron Univ Hosp, Oncol Data Sci, Barcelona, Spain

[14] DHebron Univ Hosp HUVH, Med Oncol, Barcelona, Spain

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷

关键词：

D O I：

10.1016/j.annonc.2020.08.2028

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1545P

引用

页码：S947 / S947

页数：1

共 50 条

[1] DNA damage repair (DDR) gene mutations (mut) are predictors of response to platinum-based chemotherapy in advanced pancreatic cancer (PC) patients (pts).
Verdaguer, Helena
Guardiola-Fernandez, Magda
Mancuso, Francesco M.
Acosta, Daniel
Bux, Elvira
Hernando, Jorge
Diez, Marc
Laquente, Berta
Baraibar, Iosune
Ros, Javier
Garcia, Alejandro
Matito, Judit
Martin, Agatha
Sierra, Alexandre
Villacampa, Guillermo
Molero, Cristina
Miquel, Josep M.
Vivancos, Ana
Dienstmann, Rodrigo
Macarulla, Teresa
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[2] DNA damage repair gene mutations predict the efficacy of platinum-based chemotherapy in colorectal cancer
Lin, Yan
Zhang, Jinyan
Liao, Xiaoli
Zhang, Yumei
Luo, Min
Li, Qian
Xie, Mingzhi
Liang, Chaoyong
Liao, Sina
Zheng, Yating
Hu, Xue
Huang, Mengli
Liang, Rong
Li, Yongqiang
CANCER RESEARCH, 2022, 82 (12)
[3] In silico analysis of DNA damage repair variants in advanced NSCLC patients (pts) to predict response to platinum-based chemotherapy (PBC).
Karri, Saradasri
Stein, Matthew K.
Patel, Kruti
Crawley, Melissa
Vontela, Namratha Reddy
Alloway, Taylor
Morris, Lindsay Kaye
Mays, John
Hare, Felicia
Prouet, Philippe
Byrd, Kenneth P.
Wiedower, Eric
Chandler, Jason Claud
Fenton, Moon Jung
Weksler, Benny
Schwartzberg, Lee Steven
Martin, Michael Gary
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[4] Association of somatic mutations in DNA damage repair (DDR) genes with efficacy of platinum-based chemotherapy in advanced urothelial carcinoma.
Bambury, Richard Martin
Jordan, Emmet
Zabor, Emily Craig
Bouvier, Nancy
Al-Ahmadie, Hikmat
Boyd, Mariel Elena
Mullane, Stephanie A.
Cha, Eugene K.
Ostrovnaya, Irina
Hyman, David Michael
Bochner, Bernard H.
Arcila, Maria E.
Solit, David B.
Bajorin, Dean F.
Bellmunt, Joaquim
Berger, Michael F.
Iyer, Gopa
Rosenberg, Jonathan E.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[5] Retrospective evaluation of the value of DNA damage repair gene signature in response to platinum-based chemotherapy in advanced pancreatic ductal adenocarcinoma
Tian, Tian
Fabregat Franco, Carles
Castillo, Gloria
Castet, Florian
Verdaguer, Helena
Lopez Valbuena, Daniel
Carmona-Alonso, Ana
Vivancos, Ana
Macarulla, Teresa
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[6] DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients
Gu, Weiguang
Zhuang, Wenya
Zhuang, Mengxia
He, Minhong
Li, Zhihua
DIAGNOSTIC PATHOLOGY, 2023, 18 (01)
[7] DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients
Weiguang Gu
Wenya Zhuang
Mengxia Zhuang
Minhong He
Zhihua Li
Diagnostic Pathology, 18
[8] DNA damage response and repair (DDR) mutations predict the efficacy of platinum-based chemotherapy for advanced non-small cell lung cancer: A retrospective cohort study.
Xiao, Zhiwei
Sun, Lingling
Zheng, Yating
Chen, Hanrui
Zheng, Xinting
Luo, Jiamin
Gu, Chuying
Xie, Wenzhuan
Huang, Mengli
Lin, Lizhu
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[9] Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations
Schmid, Sabine
Omlin, Aurelius
Higano, Celestia
Sweeney, Christopher
Martinez Chanza, Nieves
Mehra, Niven
Kuppen, Malou C. P.
Beltran, Himisha
Condeduca, Vincenza
Vargas Pivato de Almeida, Daniel
Cotait Maluf, Fernando
Oh, William K.
Tsao, Che-Kai
Sartor, Oliver
Ledet, Elisa
Di Lorenzo, Giuseppe
Yip, Steven M.
Chi, Kim N.
Bianchini, Diletta
De Giorgi, Ugo
Hansen, Aaron R.
Beer, Tomasz M.
Pernelle, Lavaud
Morales-Barrera, Rafael
Tucci, Marcello
Castro, Elena
Karalis, Kostas
Bergman, Andries M.
Le, Mo Linh
Zurrer-Hardi, Ursina
Pezaro, Carmel
Suzuki, Hiroyoshi
Zivi, Andrea
Klingbiel, Dirk
Schar, Sami
Gillessen, Silke
JAMA NETWORK OPEN, 2020, 3 (10)
[10] DNA damage response (DDR) gene mutations (mut), mut load, and sensitivity to chemotherapy plus immune checkpoint blockade in urothelial cancer (UC).
Galsky, Matt D.
Uzilov, Andrew V.
McBride, Russell Bailey
Wang, Huan
Patel, Vaibhav G.
Sfakianos, John
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)

← 1 2 3 4 5 →